Mean age, majority sex.The scaffold was implanted and will not return for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The absorb device was not commercially available in the u.S; however, it was similar to a device sold in the u.S.The additional adverse events referenced in the article are filed under a separate medwatch report number.
|
A2: mean age, a3: majority sex, b2, b3, c4, d6: estimated, d4: the udi# is unknown because the part and lot numbers were not provided.The absorb device was not commercially available in the u.S; however, it was similar to a device sold in the u.S.The device was not returned for analysis.A review of the lot history record and complaint history of the reported lot could not be conducted because the lot and part number were not provided.A conclusive cause for the difficulties listed cannot be determined based on the limited information available.The patient effect of death listed is consistent with the product risk profile and are therefore expected.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
|